ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75 | -90.1% | 569,566 | -61.6% | 0.01% | -92.1% |
| Q2 2023 | $756 | +8.8% | 1,481,793 | +34.3% | 0.08% | +10.1% |
| Q1 2023 | $695 | +11.9% | 1,102,975 | +15.2% | 0.07% | -10.4% |
| Q4 2022 | $621 | -99.9% | 957,348 | +57.4% | 0.08% | -44.6% |
| Q3 2022 | $1,046,000 | -10.2% | 608,037 | -35.3% | 0.14% | -20.6% |
| Q2 2022 | $1,165,000 | +666.4% | 939,214 | +304.1% | 0.18% | +775.0% |
| Q1 2022 | $152,000 | +126.9% | 232,438 | +2088.7% | 0.02% | +400.0% |
| Q1 2017 | $67,000 | -81.1% | 10,620 | -77.8% | 0.00% | -82.6% |
| Q1 2016 | $355,000 | +143.2% | 47,819 | +171.7% | 0.02% | +228.6% |
| Q4 2015 | $146,000 | +46.0% | 17,600 | +58.0% | 0.01% | +40.0% |
| Q3 2015 | $100,000 | -57.1% | 11,142 | -42.6% | 0.01% | -44.4% |
| Q2 2015 | $233,000 | – | 19,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |